Argenica Therapeutics Ltd has released a press release.
Study Shows ARG-007 Does Not Degrade
Filed with ASX ·
6ix hasn’t read this filing yet.
Argenica Therapeutics Ltd on 6ix
Earlier from Argenica Therapeutics
Later from Argenica Therapeutics
- Study Additional Information
- Grant Secured to Advance Pre-Clinical Studies Of ARG-007
- Appendix 4E & Annual Report 30 June 2021
- Argenica Achieves Manufacturing Milestones
- Argenica Partners With Linear For Phase 1 Clinical Trial
Follow Argenica Therapeutics into a list and get an email when it puts out news.
Follow Argenica Therapeutics